COMPAZINE
LOE ApproachingNDAINJECTIONINJECTABLE
Approved
Apr 1957
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 10h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
COMPAZINE (prochlorperazine) is a first-generation antipsychotic and antiemetic small molecule approved in 1957 as an injectable formulation. It is used primarily for nausea, vomiting, and psychiatric conditions, though its exact mechanism of action in this profile is not specified. This is a legacy product with long-established clinical use and safety data.
LOE Approaching
This legacy injectable faces moderate competitive pressure (30/100) with limited current linked job postings, indicating a small, stable support team managing a mature asset.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on COMPAZINE offers limited career upside given zero linked job postings and approaching LOE; roles are focused on defensive commercialization and maintenance of existing accounts. This is a stable but non-growth assignment, best suited for professionals managing portfolio complexity or preparing for portfolio rationalization.
Brand ManagerField Sales
Worked on COMPAZINE at GSK? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.